sernova corp. university of miami at coral gables conformal coating immmune protection technology

Sernova expands its IP portfolio, broadens technology scope with new licence agreement

Sernova Corp., a clinical-stage regenerative medicine company developing a ‘functional cure’ for type 1 diabetes and other chronic diseases, announced today it has entered into an exclusive, worldwide licence with the University of Miami at Coral Gables, Florida, for the commercial rights to novel conformal coating immune protection technologies. The technologies were developed by Dr.…